Literature DB >> 15862351

High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris.

Omar Farnós1, Oscar Boué, Francisco Parra, José Manuel Martín-Alonso, Odaysa Valdés, Marisdania Joglar, Leonor Navea, Paula Naranjo, Ricardo Lleonart.   

Abstract

The VP60 capsid protein from rabbit hemorrhagic disease virus (RHDV) (Spanish isolate AST/89) was cloned and expressed in Pichia pastoris. The transformed yeast was grown at high cell density and an expression level of about 1.5 g VP60L(-1) culture was obtained. The protein was detected associated with the cell debris fraction of the recombinant yeast after mechanical disruption. It was purified by a simple method and was obtained N-glycosylated with purity of approximately 70% as deduced from densitometry scan analysis. The recombinant product was antigenically similar to the native capsid protein as determined with polyclonal antibodies obtained from rabbits vaccinated with VP60 protein purified from native virus. The immunogenicity of VP60 protein purified from P. pastoris was demonstrated by ELISA in a vaccination experiment conducted with two groups of rabbits subcutaneously immunized. Animals vaccinated with VP60 in Freund's incomplete adjuvant developed a significant (p<0.01) virus-specific antibody response while the group injected with placebo remained seronegative. Preliminary results showed that the antigen administered within the cell debris fraction of the transformed yeast protected rabbits immunized by the oral route against an intramuscular challenge with 100 LD50 (16,000 hemagglutination units) of homologous virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862351     DOI: 10.1016/j.jbiotec.2005.01.013

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  5 in total

1.  Inclusion of an Arg-Gly-Asp receptor-recognition motif into the capsid protein of rabbit hemorrhagic disease virus enables culture of the virus in vitro.

Authors:  Jie Zhu; Qiuhong Miao; Yonggui Tan; Huimin Guo; Teng Liu; Binbin Wang; Zongyan Chen; Chuanfeng Li; Guangqing Liu
Journal:  J Biol Chem       Date:  2017-04-05       Impact factor: 5.157

Review 2.  Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review.

Authors:  Joana Abrantes; Wessel van der Loo; Jacques Le Pendu; Pedro J Esteves
Journal:  Vet Res       Date:  2012-02-10       Impact factor: 3.683

3.  Recombinant Lactobacillus casei Expressing Capsid Protein VP60 can Serve as Vaccine Against Rabbit Hemorrhagic Disease Virus in Rabbits.

Authors:  Li Wang; Tian Xia; Tiantian Guo; Yi Ru; Yanping Jiang; Wen Cui; Han Zhou; Xinyuan Qiao; Lijie Tang; Yigang Xu; Yijing Li
Journal:  Vaccines (Basel)       Date:  2019-11-02

Review 4.  A Review on the Methods Used for the Detection and Diagnosis of Rabbit Hemorrhagic Disease Virus (RHDV).

Authors:  Joana Abrantes; Ana M Lopes
Journal:  Microorganisms       Date:  2021-04-30

5.  Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.

Authors:  Erlinda Fernández; Jorge R Toledo; Lídice Méndez; Nemecio González; Francisco Parra; José M Martín-Alonso; Miladys Limonta; Kosara Sánchez; Ania Cabrales; Mario P Estrada; Alina Rodríguez-Mallón; Omar Farnós
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.